Comparison of surgical procedures for benign prostatic hyperplasia of medium-volume prostates: evaluation of the causes of rehospitalization from the French National Hospital Database (PMSI-MCO).
Fiche publication
Date publication
août 2023
Journal
World journal of urology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr ESCHWEGE Pascal, Pr HUBERT Jacques
Tous les auteurs :
Behr A, Salleron J, Mazeaud C, Larose C, Dagry A, Balkau B, Hubert J, Eschwège P
Lien Pubmed
Résumé
In France, transurethral resection of the prostate (TURP) is still the most commonly used surgical treatment for medium sized benign prostatic hyperplasia (BPH), but the Holmium Laser Enucleation of the Prostate (HoLEP) and laser vaporization procedures are becoming more common. For these three surgical procedures, we evaluate the initial complications, the short term (3 months) and the 4-12-month postoperative complications necessitating re-hospitalization.
Mots clés
Benign prostatic hypertrophy, Holmium Laser Enucleation of the Prostate, Laser vaporization, Transurethral resection of the prostate
Référence
World J Urol. 2023 08 7;: